• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用IBDQ-32评估哥伦比亚缓解期炎症性肠病患者的健康相关生活质量:一项横断面研究]

[Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study].

作者信息

Parra-Izquierdo Viviana, Frías-Ordoñez Juan Sebastián, Márquez Juan Ricardo, Puentes-Manosalva Fabián Eduardo, Sarmiento Fernando, García-Duperly Rafael, Vargas Melquisedec, Reyes Gustavo, Samper Carolina, Barreiro-de-Acosta Manuel

机构信息

Gastroenterología y Reumatología, Hospital Internacional de Colombia, Bucaramanga, Colombia; Fundación Colombiana de Enfermedad Inflamatoria Intestinal, Bucaramanga, Colombia.

Medicina interna. Universidad de La Sabana. Chia, Cundinamarca, Colombia.

出版信息

Rev Gastroenterol Peru. 2023 Apr-Jun;43(2):95-103.

PMID:37597222
Abstract

In Colombia there are no data about perception of quality of life (QoL) in inflammatory bowel disease (IBD). The aim of this study was to determine the perception of QoL by means of the IBDQ-32 questionnaire in patients with IBD from a sample of patients from different referral centers. We carried out a cross-sectional study in adults with IBD in clinical remission, in outpatient follow-up, in 3 institutions in different cities, between June 2022 and November 2022, eligible subjects were identified, information was collected on different dates, about socio-demographic and clinical aspects, and the IBDQ-32 questionnaire was evaluated on one occasion. Descriptive and analytical analysis of the variables evaluated was performed. 80 patients, 70% women, mean age 38.5(range 18-72; SD 13.25) years. 67.5% ulcerative colitis (UC), 32.5% Crohn's disease (CD). Moderate QoL involvement (median 150 points, interquartile range118.3-181.5) was found in IBD, in UC median 151 (interquartile range120-174.75) points, while in CD 133 (interquartile range106.25-186.25) points. There was greater involvement in the systemic domain, with median 21 (interquartile range 15.8-27) points, and 18.5 (interquartile range 12.8-25.3) points, for UC and CD, respectively. The least affected corresponded to the digestive domain and social function, in median UC 48.5 (interquartile range 40-58.3), and 27(interquartile range 20.8-33); in median CD 43 (interquartile range 35.5-61.75) and 24.5(interquartile range 18-32.5), respectively. No statistically significant differences were found. This study provides unique information about QoL of patients with IBD in Colombia. It is necessary to continue reinforcing the accompaniment, support, and education of patients with IBD.

摘要

在哥伦比亚,尚无关于炎症性肠病(IBD)患者生活质量(QoL)认知情况的数据。本研究旨在通过IBDQ - 32问卷,确定来自不同转诊中心的IBD患者样本对生活质量的认知。2022年6月至2022年11月期间,我们在不同城市的3家机构对处于临床缓解期、接受门诊随访的成年IBD患者开展了一项横断面研究。确定符合条件的受试者后,在不同日期收集了有关社会人口学和临床方面的信息,并一次性评估了IBDQ - 32问卷。对所评估变量进行了描述性和分析性分析。80名患者,70%为女性,平均年龄38.5岁(范围18 - 72岁;标准差13.25)。67.5%为溃疡性结肠炎(UC),32.5%为克罗恩病(CD)。发现IBD患者的生活质量受中度影响(中位数150分,四分位间距118.3 - 181.5),UC患者中位数为151分(四分位间距120 - 174.75),而CD患者为133分(四分位间距106.25 - 186.25)。全身领域受影响更大,UC患者中位数为21分(四分位间距15.8 - 27),CD患者为18.5分(四分位间距12.8 - 25.3)。受影响最小的是消化领域和社会功能,UC患者中位数分别为48.5分(四分位间距40 - 58.3)和27分(四分位间距20.8 - 33);CD患者中位数分别为43分(四分位间距35.5 - 61.75)和24.5分(四分位间距18 - 32.5)。未发现统计学上的显著差异。本研究提供了关于哥伦比亚IBD患者生活质量的独特信息。有必要继续加强对IBD患者的陪伴、支持和教育。

相似文献

1
[Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study].[使用IBDQ-32评估哥伦比亚缓解期炎症性肠病患者的健康相关生活质量:一项横断面研究]
Rev Gastroenterol Peru. 2023 Apr-Jun;43(2):95-103.
2
Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.巴西炎症性肠病患者的生活质量、工作生产力受损和医疗资源利用情况。
World J Gastroenterol. 2019 Oct 14;25(38):5862-5882. doi: 10.3748/wjg.v25.i38.5862.
3
Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia.哥伦比亚炎症性肠病多中心队列患者的临床与治疗特征
Gastroenterol Hepatol. 2023 Oct;46(8):585-593. doi: 10.1016/j.gastrohep.2022.11.006. Epub 2022 Dec 1.
4
ASSESSMENT OF QUALITY OF LIFE IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH MILD ACTIVITY AND IN CLINICAL REMISSION.评估轻中度活动期和临床缓解期老年炎症性肠病患者的生活质量。
Arq Gastroenterol. 2024 Jul 19;61:e24017. doi: 10.1590/S0004-2803.24612024-017. eCollection 2024.
5
Differences in the Quality of Life of Patients Recently Diagnosed with Crohn's Disease and Ulcerative Colitis.最近被诊断患有克罗恩病和溃疡性结肠炎的患者的生活质量差异。
Int J Environ Res Public Health. 2023 Aug 14;20(16):6576. doi: 10.3390/ijerph20166576.
6
Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.哥伦比亚基于全国代表性索赔数据库的人口统计学和地区炎症性肠病流行病学趋势以及对哥伦比亚患者病例系列中炎症性肠病表型的特征描述。
Medicine (Baltimore). 2021 Feb 19;100(7):e24729. doi: 10.1097/MD.0000000000024729.
7
Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Clinical Remission: What Should We Look For?炎症性肠病缓解期患者的健康相关生活质量:我们应该关注什么?
Medicina (Kaunas). 2022 Mar 27;58(4):486. doi: 10.3390/medicina58040486.
8
Influence of inflammatory bowel disease on different dimensions of quality of life.炎症性肠病对生活质量不同维度的影响。
Eur J Gastroenterol Hepatol. 2001 May;13(5):567-72. doi: 10.1097/00042737-200105000-00017.
9
Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment.抗 TNFα 治疗一年后炎症性肠病患者生活质量的恢复。
J Crohns Colitis. 2012 Oct;6(9):881-6. doi: 10.1016/j.crohns.2012.01.019. Epub 2012 Feb 14.
10
Validation and reliability of the Turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病炎症性肠病问卷土耳其语版的验证和可靠性。
Turk J Gastroenterol. 2020 Aug;31(8):566-572. doi: 10.5152/tjg.2020.19553.